ADC Therapeutics Expands to Third Program Using Synaffix’s ADC Platform under Existing Agreement

28 May 2019

AMSTERDAM, NETHERLANDS – May 28, 2019 – Synaffix B.V., a Dutch biotechnology company focused on the advancement of its clinical-stage antibody-drug conjugate (ADC) technology for the development of best-in-class ADCs, announces that ADC Therapeutics has triggered a...

BioFit Marseille – December 10 / 11

28 May 2019

Diede will attend BioFit Marseille.   Home...

Nordic Life Science days Malomo Copenhagen – September 10 / 12

28 May 2019

Daniela will attend the Nordic Life Science days in Malomo Copenhagen....

CrownBio 2019 Janssen Research Campus Beerse – June 27

28 May 2019

Daniela and Diede will attend the CrownBio/Janssen cellular therapies symposium 2019.   https://www.crownbio.com/crown-janssen-2019

ASCO: American Society of Clinical Oncology Annual Meeting – May 31 / June 4

28 May 2019

Edward will attend ASCO 2019 in Chicago. https://www.asco.org/

Cristal Therapeutics to present data at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting on lead clinical candidate CPC634 in patients with solid tumors

17 May 2019

• Three poster presentations will be given by the company and its collaborators Cristal Therapeutics • Florence Atrafi, MD, a clinical investigator on the phase 1 NAPOLY study, has received a prestigious ASCO Merit Award in recognition of her abstract that highlights...